EBE-A22

CAT: 0804-HY-14347-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-14347-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
EBE-A22 is a derivative of PD153035, which can inhibit the phosphorylation of ErbB-1, but EBE-A22 does not have this activity.
CAS Number
[229476-53-3]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/EBE-A22.html
Concentration
10mM
Purity
99.76
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
BrC1=CC(N(C)C2=NC=NC3=CC(OC)=C(OC)C=C23)=CC=C1
Molecular Formula
C17H16BrN3O2
Molecular Weight
374.23
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Goossens JF, et al. DNA interaction of the tyrosine protein kinase inhibitor PD153035 and its N-methyl analogue. Biochemistry. 2001 Apr 17;40 (15) :4663-71.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-118773-01MreB Perturbing Compound A22 (hydrochloride)
HY-118773RMreB Perturbing Compound A22 (hydrochloride) (Standard)
HY-161346-01EBET-1055
HY-177244EBET-1593
HY-161387EBET-590
HY-161346A-01(Rac) -EBET-1055

Alternative Products

CatalogName
M17448-01EBE-A22
A15074-50EBE-A22 50mg
A15074-5EBE-A22 5mg
A15074-25EBE-A22 25mg
A15074-100EBE-A22 100mg
A15074-2EBE-A22 2mg
A15074-10EBE-A22 10mg
A15074-200EBE-A22 200mg
448047EBE-A 22
555259A22 hydrochloride

Popular Products